June 2, 2015.
Following the "morning after" pill's release from prescription requirement in Germany on March 14 this year, sales increased in April by more than 10 per cent to 55.000 packs, according to data from INSIGHT Health. The increase also represents a 25 percent gain on the strongest sales month in 2014.
Almost 100 percent of emergency contraceptives in Germany are sold by ellaOne and HRA-Pharma's PiDaNa. While the monthly sales quantity of ellaOne more than doubled during the last six months, PiDaNa shows a decrease of more than a third in its monthly sales quantity. This however is because PiDaNa's Levonorgestrel was not released from prescription requirement until after ellaOnes’ Ulipristal, reports INSIGHT.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.
2 Commerce Drive
Cranbury, NJ 08512